Theravance Biopharma, Inc. Public Float
Theravance Biopharma, Inc. (TBPH) had Public Float of $448.60 million as of 2025-06-30, per its 10-K filed 2026-03-23.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-23
- 2025-06-30: Entity Public Float $448.60M.
- 2024-06-30: Entity Public Float $334.90M.
- 2023-06-30: Entity Public Float $458.80M.
- 2022-06-30: Entity Public Float $677.00M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $448.60M 10-K · filed 2026-03-23 |
| 2024-06-30 | $334.90M 10-K · filed 2025-03-07 |
| 2023-06-30 | $458.80M 10-K · filed 2024-03-01 |
| 2022-06-30 | $677.00M 10-K · filed 2023-03-01 |
| 2021-06-30 | $882.10M 10-K · filed 2022-02-28 |
| 2020-06-30 | $1.28B 10-K · filed 2021-02-26 |
| 2019-06-30 | $893.46M 10-K · filed 2020-02-27 |
| 2018-06-30 | $1.21B 10-K · filed 2019-02-28 |
| 2017-06-30 | $1.71B 10-K · filed 2018-02-28 |
| 2016-06-30 | $842.60M 10-K · filed 2017-03-01 |
| 2015-06-30 | $219.24M 10-K · filed 2016-03-11 |
| 2014-06-30 | $565.28M 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |